Clinical trial Recruiting at 1 site Observational Ages 50 and up

Automating the assessment of delirium severity in ICU patients

Official title: Harnessing the Power of Technology to Transform Delirium Severity Measurement in the ICU

Run by Mayo Clinic · NCT06172491 · Data updated 2026-11-12

This study is testing a new way to measure how severe delirium is in ICU patients over 50 by using bedside cameras and comparing it to traditional methods.

More Delirium trials

Quick facts

Study typeObservational
Ages50 Years and up
SexAll
Enrollment400 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedJanuary 15, 2023
Main results expectedMay 31, 2027
Study endsMay 31, 2028
Registry record updatedApril 8, 2026
Trial IDNCT06172491 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are ICU patients over 50 years old who are expected to stay in the ICU for more than 24 hours and are not admitted for substance-related issues.

Probably not a fit

Patients admitted for acute alcohol intoxication, drug overdose, or those with acute neuronal injury may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop a passive digital marker (PDM) to assess delirium severity in ICU patients over 50 years old. Participants will be monitored using bedside cameras for 24 hours a day, with study staff conducting assessments four times daily to compare the PDM's performance against established delirium severity tools. The study will evaluate the reliability of a trained convolutional neural network in measuring delirium severity and its acceptability among ICU staff and patients. The goal is to enhance the accuracy and efficiency of delirium assessments in critical care settings.

Why it matters

Potential benefit: If successful, this study could lead to more accurate and timely assessments of delirium severity, improving patient care in the ICU.

How similar studies have gone: While the use of digital markers and AI in healthcare is an emerging field, this specific approach to delirium assessment is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: • Age \>50;

* Estimated length of stay \>24 hours in ICU; and
* Are not admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.

Exclusion Criteria:

* Admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.
* Admitted for acute neuronal injury
* Unable to communicate with research team due to sensory deficits (aphasic, blind, deaf) or language (does not speak English)

Where it's running

  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.